These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21511027)

  • 1. Phenylalanine induces Burkholderia cenocepacia phenylacetic acid catabolism through degradation to phenylacetyl-CoA in synthetic cystic fibrosis sputum medium.
    Yudistira H; McClarty L; Bloodworth RA; Hammond SA; Butcher H; Mark BL; Cardona ST
    Microb Pathog; 2011 Sep; 51(3):186-93. PubMed ID: 21511027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenylacetyl Coenzyme A, Not Phenylacetic Acid, Attenuates CepIR-Regulated Virulence in Burkholderia cenocepacia.
    Lightly TJ; Frejuk KL; Groleau MC; Chiarelli LR; Ras C; Buroni S; Déziel E; Sorensen JL; Cardona ST
    Appl Environ Microbiol; 2019 Dec; 85(24):. PubMed ID: 31585996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic cystic fibrosis sputum medium diminishes Burkholderia cenocepacia antifungal activity against Aspergillus fumigatus independently of phenylacetic acid production.
    Lightly TJ; Phung RR; Sorensen JL; Cardona ST
    Can J Microbiol; 2017 May; 63(5):427-438. PubMed ID: 28178425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of phenylacetic acid degradation genes of Burkholderia cenocepacia K56-2.
    Hamlin JN; Bloodworth RA; Cardona ST
    BMC Microbiol; 2009 Oct; 9():222. PubMed ID: 19835630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Hydroxyphenylacetic acid induces the Burkholderia cenocepacia phenylacetic acid degradation pathway - toward understanding the contribution of aromatic catabolism to pathogenesis.
    Imolorhe IA; Cardona ST
    Front Cell Infect Microbiol; 2011; 1():14. PubMed ID: 22919580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic Cystic Fibrosis Sputum Medium Regulates Flagellar Biosynthesis through the flhF Gene in Burkholderia cenocepacia.
    Kumar B; Cardona ST
    Front Cell Infect Microbiol; 2016; 6():65. PubMed ID: 27379216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The attenuated virulence of a Burkholderia cenocepacia paaABCDE mutant is due to inhibition of quorum sensing by release of phenylacetic acid.
    Pribytkova T; Lightly TJ; Kumar B; Bernier SP; Sorensen JL; Surette MG; Cardona ST
    Mol Microbiol; 2014 Nov; 94(3):522-36. PubMed ID: 25155974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A functional phenylacetic acid catabolic pathway is required for full pathogenicity of Burkholderia cenocepacia in the Caenorhabditis elegans host model.
    Law RJ; Hamlin JN; Sivro A; McCorrister SJ; Cardama GA; Cardona ST
    J Bacteriol; 2008 Nov; 190(21):7209-18. PubMed ID: 18776009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A c-di-GMP-Modulating Protein Regulates Swimming Motility of
    Kumar B; Sorensen JL; Cardona ST
    Front Cell Infect Microbiol; 2018; 8():56. PubMed ID: 29541628
    [No Abstract]   [Full Text] [Related]  

  • 10. Insights on the regulation of the phenylacetate degradation pathway from Escherichia coli.
    Fernández C; Díaz E; García JL
    Environ Microbiol Rep; 2014 Jun; 6(3):239-50. PubMed ID: 24983528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerobic catabolism of phenylacetic acid in Pseudomonas putida U: biochemical characterization of a specific phenylacetic acid transport system and formal demonstration that phenylacetyl-coenzyme A is a catabolic intermediate.
    Schleissner C; Olivera ER; Fernández-Valverde M; Luengo JM
    J Bacteriol; 1994 Dec; 176(24):7667-76. PubMed ID: 8002592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catabolism of phenylacetic acid in Escherichia coli. Characterization of a new aerobic hybrid pathway.
    Ferrández A; Miñambres B; García B; Olivera ER; Luengo JM; García JL; Díaz E
    J Biol Chem; 1998 Oct; 273(40):25974-86. PubMed ID: 9748275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenylacetyl coenzyme A is an effector molecule of the TetR family transcriptional repressor PaaR from Thermus thermophilus HB8.
    Sakamoto K; Agari Y; Kuramitsu S; Shinkai A
    J Bacteriol; 2011 Sep; 193(17):4388-95. PubMed ID: 21725002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Belfast Agar-a simple laboratory medium to separate Pseudomonas aeruginosa from pan-resistant Burkholderia cenocepacia isolated from the sputum of patients with cystic fibrosis (CF).
    Caskey S; Moore JE; McCaughan J; Rendall JC
    Br J Biomed Sci; 2018 Apr; 75(2):101-103. PubMed ID: 29513134
    [No Abstract]   [Full Text] [Related]  

  • 15. Phenotypic characterization of trimeric autotransporter adhesin-defective bcaC mutant of Burkholderia cenocepacia: cross-talk towards the histidine kinase BCAM0218.
    Pimenta AI; Mil-Homens D; Pinto SN; Fialho AM
    Microbes Infect; 2020 Oct; 22(9):457-466. PubMed ID: 32554104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the TetR-Type Regulator PaaR in the Regulation of Pristinamycin I Biosynthesis through an Effect on Precursor Supply in Streptomyces pristinaespiralis.
    Zhao Y; Feng R; Zheng G; Tian J; Ruan L; Ge M; Jiang W; Lu Y
    J Bacteriol; 2015 Jun; 197(12):2062-71. PubMed ID: 25868645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel method for investigating Burkholderia cenocepacia infections in patients with cystic fibrosis and other chronic diseases of the airways.
    Wijers CD; Vagedes R; Weingart C
    BMC Microbiol; 2016 Sep; 16(1):200. PubMed ID: 27586172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Essential Genome of Burkholderia cenocepacia H111.
    Higgins S; Sanchez-Contreras M; Gualdi S; Pinto-Carbó M; Carlier A; Eberl L
    J Bacteriol; 2017 Nov; 199(22):. PubMed ID: 28847919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum.
    Drevinek P; Holden MT; Ge Z; Jones AM; Ketchell I; Gill RT; Mahenthiralingam E
    BMC Infect Dis; 2008 Sep; 8():121. PubMed ID: 18801206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomic profiling of Burkholderia cenocepacia in synthetic cystic fibrosis sputum medium reveals nutrient environment-specific production of virulence factors.
    Jaiyesimi OA; McAvoy AC; Fogg DN; Garg N
    Sci Rep; 2021 Nov; 11(1):21419. PubMed ID: 34725378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.